Clinical Trials in Kumamoto, Kumamoto, Japan
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Type 2 Diabetes
Novo Nordisk A/S264 enrolled15 locationsNCT07271251
Recruiting
General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
Diabetes Mellitus, Type 1
Novo Nordisk A/S630 enrolled43 locationsNCT06807190